期刊文献+

新疆维汉弥漫大B细胞淋巴瘤中Bcl-6 c-myc基因易位的差异性研究 被引量:3

Difference of Bcl-6 and c-myc gene translocation between Xinjiang Uygur and Han diffused large B-cell lymphoma subtypes
下载PDF
导出
摘要 目的:探讨新疆维吾尔族、汉族弥漫大B细胞淋巴瘤(diffuse large B-cell lymphoma,DLBCL)患者Bcl-6、c-myc基因易位的差异及其临床意义。方法:采用荧光免疫原位杂交(FISH)方法,对233例DLBCL活体石蜡切片进行Bcl-6、c-myc基因检测。观察Bcl-6、c-myc基因易位与DLBCL患者临床资料的关系,并对不同民族在不同亚型DLBCL中Bcl-6、c-myc基因易位的情况进行比较。结果:233例DLBCL中,Bcl-6基因重排51例,占21.89%;c-myc基因重排39例,占16.74%;Bcl-6基因易位的表达与患者年龄、性别、发病部位、临床分期和LDH水平无显著相关(P>0.05),而与民族、IPI评分、结外侵犯、B症状、DLBCL不同亚型和近期疗效有相关性(P<0.05);c-myc基因易位的表达与患者年龄、性别、发病部位、临床分期、LDH水平和DLBCL不同亚型无明显相关性(P>0.05),而与民族、IPI评分、结外侵犯、B症状和近期疗效有相关性(P<0.05);维、汉不同民族GCB中Bcl-6、c-myc基因易位比较差异均无统计学意义(P>0.05);维、汉不同民族非生发中心活化B细胞(non-GCB)中Bcl-6、c-myc基因易位比较差异有统计学意义(P<0.05)。结论:Bcl-6,C-myc基因易位的表达与维、汉不同民族、IPI评分、结外侵犯、B症状和近期疗效有相关性;维、汉民族non-GCB亚组中Bcl-6、c-myc基因易位存在差异。 Objective:To investigate the clinical significance of Bcl-6, c-myc gene abnormalities in Xinjiang Uygur and Han diffused large B-cell lymphoma (DLBCL) subtypes. Methods:Bcl-6, c-myc gene was detected by fluorescence in situ hybridization in 233 patients with DLBCL . A relationship was observed among Bcl-6, c-myc gene translocation, and clinical data in DLBCL patients. In addition, a difference was observed among Bcl-6, c-myc gene translocation, and different ethnic groups in different subtypes of DLB-CL. Results:Among the 233 patients, 51 cases (21.89%) had rearranged Bcl 6 gene, and 39 cases (16.74%) had rearranged c-myc gene. Bcl-6 gene translocation and expression was related with age, gender, disease location, clinical stage, and LDH levels (P〉0.05), but was not related with nationality , international prognostic index score, extranodal involvement, B symptoms, DLBCL subtypes, and recent efficacy (P〈0.05);c-myc gene translocation and expression was related with age, gender, disease location, clinical stage LDH levels, and DLBCL subtypes (P〉0.05), but was not related with nationality, IPI score, extranodal involvement, B symptoms, and recent efficacy (P〈0.05). In the Uygur and Han GCB groups, Bcl-6, c-myc gene translocation showed no significant difference (P〉0.05). By contrast, in the Uygur and Han non-GCB groups, Bcl-6, c-myc gene translocation showed significant difference (P〉0.05). Conclusion:Bcl-6, C-myc gene translocation was related with age, gender, disease location, clinical stage, and LDH levels. Bcl-6 gene translocation was also correlated with different subtypes of DLBCL.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2014年第19期1244-1248,共5页 Chinese Journal of Clinical Oncology
基金 新疆维吾尔自治区科技支疆项目(编号:201191156)资助~~
关键词 BCL-6基因 c—myc基因 弥漫大B细胞淋巴瘤 Bcl-6 gene c-myc gene diffuse large B-cell lymphoma
  • 相关文献

参考文献15

  • 1Swerdlow SH,Campo E,Harris NL,et al.WHO classification of tumors of haematopoietic and lymphoid tissues[J].IARC:Lyon,2008.
  • 2Alizadeh AA,Eisen MB,Davis RE,et al.Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling[J].Nature,2000,403(6769):503-511.
  • 3Hans CP,Weisenburger DD,Greiner TC,et al.Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray[J].Blood,2004,103(1):275-282.
  • 4罗东兰,刘艳辉,张芬,徐方平,颜黎栩,陈洁,许洁,骆新兰,庄恒国.同时发生myc和bcl-2/IgH或bcl-6易位的B细胞淋巴瘤临床病理特征[J].中华病理学杂志,2013,42(9):584-588. 被引量:12
  • 5Basso K,Dalla-Favera R.Roles of BCL6 in normal and transformed germinal center B cells[J].Immunol Rev,2012,247(1):172-183.
  • 6Culpin RE,Sieniawski M,Angus B,et al.Prognostic significance of immunohistochemistry-based markers and algorithms in immunochemotherapy-treated diffuse large B cell lymphoma patients[J].Histopathology,2013,63(6):788-801.
  • 7Salles G,de Jong D,Xie W,et al.Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma:a study from the Lunenburg Lymphoma Biomarker Consortium[J].Blood,2011,117(26):7070-7078.
  • 8Seki R,Ohshima K,Fujisaki T,et al.Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era[J].Cancer Sci,2009,100(10):1842-1847.
  • 9Ruzinova MB,Caron T,Rodig SJ,et al.Altered subcellular localization of c-Myc protein identifies aggressive B-cell lymphomas harboring a c-MYC translocation[J].Am J Surg Pathol,2010,34(6):882-891.
  • 10Gouveia GR,Siqueira SA,Pereira J.Pathophysiology and molecular aspects of diffuse large B-cell lymphoma[J].Rev Bras Hematol Hemoter,2012,34(6):447-451.

二级参考文献40

  • 1Swerdlow SH, Campo E, Harris NL, et al. World Health Organiza-tion Classification of Tumors of Haematopoietic and LymphoidTissues[M]. Lyon: IARC Press, 2008:164.
  • 2Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation ofthe molecular classification of diffuse large B—cell lymphoma by im-munohistochemistry using atissue microarray J]. Blood, 2004, 103(1):275-282.
  • 3Gouveia GR, Siqueira SA, Pereira J. Pathophysiology and molecu-lar aspects of diffuse large B—cell lymphoma[J|. Rev Bras HematolHemoter, 2012, 34(6):447-451.
  • 4Smith SM, AnastasiJ, Cohen KS, et al. The impact of MYC expres-sion in lymphoma biology: beyond Burkitt lymphoma[J]. BloodCells Mol Dis, 2010, 45(4):317-323.
  • 5Aukema SM, Siebert R, Schuuring E, et al. Double—hit B—cell lym-phomas[J]. Blood, 2011,117(8):2319-2331.
  • 6Li T, Medeiros LJ, Lin P, et al. Immunohistochemical profile andfluorescence in situ hybridization analysis of diffuse large B—celllymphoma innorthern China [J]. Arch Pathol Lab Med, 2010, 134(5):759-765.
  • 7Zhang HW, Chen ZW, Li SH, et al. Clinical significance and prog-nosis of MYC translocation in diffuse large B—cell lymphomaQ]. He-matol Oncol, 2011, 29(4):185-189.
  • 8Mossafa H, Damotte D, Jenabian A, et al. Non—Hodgkin's lympho-mas with Burkitt—like cells are associated with c—Myc amplificationand poor prognosis]]]. Leuk Lymphoma, 2006,47(9):1885-1893.
  • 9Stasik CJ, Nitta H, Zhang W, et al. Increased MYC gene copy num-ber correlates with increased mRNA levels in diffuse large B—celllymphomaj]. Haematologica, 2010, 95⑷:597-603.
  • 10Yoon SO, Jeon YK, Paik JH, et al. MYC translocation and an in-creased copy number predict poor prognosis in adult diffuse largeB—cell lymphoma(DLBCL), especially in germinal centre—like Bcell (GCB) typej]. Histopathology, 2008, 53(2):205-217.

共引文献21

同被引文献59

  • 1申志华,李飞虹,姜汉国,揭伟.PTTG与C-MYC在非霍奇金淋巴瘤中的表达及意义[J].现代肿瘤医学,2008,16(1):99-101. 被引量:5
  • 2Savage KJ, Johnson NA, Ben-Neriah S, et al. MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy[J]. Blood, 2009, 114(17): 3533-3537.
  • 3Akyurek N, Uner A, Benekli M, et al. Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubiein, vincristine, and prednisone plus rituximab[J]. Cancer, 2012, 118 (17): 4173-4183.
  • 4Shortt J, Martin BP, Newbold A, et al. Combined inhibition of PI3K-related DNA-damage response kinases and mTORC1 induces apoptosis in MYC-driven B-cell lymphomas[J]. Blood, 2013, 121(15): 2964-2974.
  • 5Buendia MA, Bourre L, Cairo S. Myc target miRs and liver cancer: small molecules to get Myc sick[J]. Gastroenterology, 2012, 142(2): 214-218.
  • 6Huang WT, Lu N, Guo L. Significance and application of e-rnyc in diffuse large B-cell lymphoma[J]. Zhonghua Bing Li Xue Za Zhi, 2013, 42(9): 638-640.
  • 7Dang CV. MYC on the path to cancer[J]. Cell, 2012, 149(1): 22-35.
  • 8Psathas JN, Thomas-Tikhonenko A. MYC and the art of microRNA maintenance[J]. Cold Spring Harb Perspeet Med, 2014, 4(8): a014175.
  • 9Slack GW, Gascoyne RD. MYC and aggressive B-cell lymphomas[J]. Adv Anat Pathol, 2011, 18(3):219-228.
  • 10Levens D. You don't muck with MYC[J]. Genes Cancer, 2010, 1(6) : 547-554.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部